Conference abstractPublished 21 Sep 2018
The DNA sequencing revolution as an important singularity
Mayo Clinic, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Advances in DNA sequencing, based upon massively parallel sequencing, has resulted in dramatic advances in DNA sequence output in the past few years. It is now possible to generate tera-bases of accurate DNA sequence with a single run on several DNA sequencing platforms. This has then made it possible to characterize alterations that occur during cancer development. Genomic alterations can be characterized by targeted sequencing of genes that are frequently altered during cancer development, by sequencing of the entire exome, transcriptome sequencing, and even by whole genome sequencing. Each of these has their own inherent strengths and weaknesses. This talk will describe why I believe that the best strategy for moving forward for the management of cancer patients is whole genome sequencing (WGS). This can currently be done reliably and inexpensively on two competing platforms. The first is the Illumina sequencing platform and the second is from BGI. WGS is a comprehensive technology that can detect all the alterations in a cancer genome and will also describe how and why this may prove to be the best approach for the management of cancer patients.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “David I Smith”
